DEA schedule
Is Lamictal a controlled substance?
Lamictal contains lamotrigine. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Lamictal (lamotrigine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and lamotrigine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Lamictal?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 17 prescription listings from 1 labelers, none with a DEA schedule |
| DEA controlled substances list | lamotrigine is not on the list |
Lamictal NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0173-0642 | LAMICTAL | tablet | 100 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0643 | LAMICTAL | tablet | 150 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0644 | LAMICTAL | tablet | 200 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0633 | LAMICTAL | tablet | 25 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0756 | LAMICTAL XR | tablet, film coated, extended release | 100 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0757 | LAMICTAL XR | tablet, film coated, extended release | 200 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0754 | LAMICTAL XR | tablet, film coated, extended release | 25 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0781 | LAMICTAL XR | tablet, film coated, extended release | 250 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0761 | LAMICTAL XR | tablet, film coated, extended release | 300 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0755 | LAMICTAL XR | tablet, film coated, extended release | 50 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0699 | LAMICTAL | tablet, for suspension | 2 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0527 | LAMICTAL | tablet, for suspension | 25 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0526 | LAMICTAL | tablet, for suspension | 5 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0776 | LAMICTAL ODT | tablet, orally disintegrating | 100 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0777 | LAMICTAL ODT | tablet, orally disintegrating | 200 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0772 | LAMICTAL ODT | tablet, orally disintegrating | 25 mg/1 | GlaxoSmithKline LLC | None |
| 0173-0774 | LAMICTAL ODT | tablet, orally disintegrating | 50 mg/1 | GlaxoSmithKline LLC | None |
Questions
Is Lamictal a controlled substance?
No. Lamictal (lamotrigine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and lamotrigine is not on the DEA controlled substances list.
Is Lamictal a narcotic?
No. Lamictal (lamotrigine) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Anti-epileptic Agent and Mood Stabilizer.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Lamictal
- What is Lamictal used for?FDA label uses
- Generic for LamictalFDA Orange Book
- What is Lamotrigine used for?FDA label uses
- Is Lamotrigine a controlled substance?Federal schedule
- Generic for LamliqueFDA Orange Book
- Generic for SubveniteFDA Orange Book
- Generic for Lamictal XRFDA Orange Book
- Generic for Lamictal CDFDA Orange Book
- Generic for Lamictal ODTFDA Orange Book
- Anti-epileptic Agents listFDA drug class
- Mood Stabilizers listFDA drug class
- NDC 0173-0526Lamictal NDC record
- NDC 0173-0527Lamictal NDC record
- NDC 0173-0633Lamictal NDC record